7th Eurasian Hematology Oncology Summit


 

2020 Update on High-Risk MDS: Does Aza Improve OS/ORR? How to Minimize Toxicity? Is Cytarabine Still the SoC? Are Novel Agents Promising?

0 views
December 11, 2020
Comments 0
Login to view comments. Click here to Login